Table 1.
The content of phospholipids, lysophospholipids, and sphingomyelin by normalizing the intensities of individual peak areas to the areas of internal standards.
| Control vs. Benign | Control vs. Cancer | Benign vs. Cancer | ||||||
|---|---|---|---|---|---|---|---|---|
| Species | Ben/Con | p | Species | Can/Con | p | Species | Can/Ben | p |
| LPE (o-16:0) | 0.368 | <0.001 | PE (16:0/22:6) | 3.155 | <0.001 | PI (18:1/20:4) | 0.718 | 0.014 |
| PE1 (6:0/22:6) | 1.832 | <0.001 | PE (18:0/22:6) | 2.606 | <0.001 | PE (16:0/18:1) | 1.544 | 0.016 |
| PI (18:0/22:6) | 1.889 | 0.001 | LPE (22:6) | 1.822 | <0.001 | PI (18:0/20:4) | 0.787 | 0.040 |
| PE (16:0/22:6) | 1.774 | 0.001 | LPC (22:6) | 2.276 | <0.001 | PI (16:0/18:1) | 0.693 | 0.042 |
| LPC (18:0) | 0.661 | 0.001 | PC (18:0/22:6) | 1.754 | <0.001 | LPC (22:6) | 1.460 | 0.055 |
| PC (16:0/22:6) | 1.779 | 0.001 | PC (16:0/22:6) | 1.779 | <0.001 | SM (d18:1/14:0) | 0.724 | 0.055 |
| LPE (18:1) | 0.621 | 0.001 | LPE (18:2) | 0.648 | 0.001 | PI (16:0/20:4) | 0.746 | 0.055 |
| PE (o-18:0/22:6) | 1.889 | 0.001 | LPE (18:1) | 0.618 | 0.001 | SM (d18:1/23:0) | 0.835 | 0.066 |